))
#38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals
Manage episode 417197264 series 3478706
Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Join us on the latest episode! Our Guest: Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals.
What you'll get out of this episode:
- Dr. Michael Kyle's Background: Insights into his journey from medical practice to becoming SVP & Chief Medical Officer of Currax Pharmaceuticals.
- Understanding Obesity: A discussion on different types of obesity and the importance of tailored treatments.
- Global Perspectives: Comparing how the U.S. and European countries handle obesity and the lessons to be learned.
- Evolving Treatments: The parallel evolution of hypertension and obesity treatments.
- Behavioral Approaches: The importance of sustainable lifestyle changes and behavior modification in addressing obesity.
To learn more about our guests and their companies:
LinkedIn https://www.linkedin.com/in/michael-l-kyle/
Company LinkedIn https://www.linkedin.com/company/currax-pharmaceuticals-llc/
Website https://www.curraxpharma.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
40 episodes
Share
